Sort
39,280 grants matching “leukemia”
CCR Genomics Core
$1,245,898Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
A Search for Genes that Regulate Stem Cells
$1,244,709Stanford University · P01 · FY2005 · DK
Architecture and Trajectory of Acquired Resistance to Therapy in AML
$1,243,548Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2024 · CA
Washington University/Siteman Cancer Center Lead Academic Site
$1,241,704Nancy L Bartlett · Washington University · UG1 · FY2024 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,241,003Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
NHGRI/DIR Technology Transfer Program
$1,240,530Eric Green · National Human Genome Research Institute · Z01 · FY2008 · HG
Regulation And Function Of Retroelements
$1,240,406Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Cancer Biology and Genetics
$1,240,285Harold Varmus · National Human Genome Research Institute · ZIA · FY2013 · HG
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,240,277Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanisms of nonsense-mediated mRNA decay target selection
$1,240,199John Hogg · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Washington University/Siteman Cancer Center Lead Academic Site
$1,239,849Nancy L Bartlett · Washington University · UG1 · FY2025 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,238,889Claire F Verschraegen · Ohio State University · UG1 · FY2021 · CA
Systems Biology of Tumor Progression and Drug Resistance
$1,238,106Andrea Califano · Columbia University Health Sciences · U01 · FY2016 · CA
Kinetic Biomarker for CLL Prognosis
$1,237,577Kinemed, Inc. · R44 · FY2004 · CA
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)
$1,237,500Stephanie J Lee · Fred Hutchinson Cancer Research Center · U54 · FY2010 · AI
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,236,369Brian J Druker · Oregon Health & Science University · U01 · FY2019 · CA
Programming T Cell Fates for Therapeutic Use
$1,233,165Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Systems Biology of Tumor Progression and Drug Resistance
$1,232,072Andrea Califano · Columbia University Health Sciences · U01 · FY2015 · CA
WHOLE GENOME SEQUENCING OF MYELODYSPLASTIC SYNDROMES
$1,232,000Timothy A Graubert · Washington University · RC2 · FY2010 · HL
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,231,558Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Clinical Trials with Immunotoxins
$1,230,498Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Clinical, Immunological and Genetic Analyses of ALPS and Related Immunedysregulatory Disorders
$1,230,412V Koneti Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The Center for Systemic Control of Cyto-Networks
$1,230,000Chih-Ming Ho · University Of California Los Angeles · PN2 · FY2010 · EY
Nuclear Structure and Gene Expression
$1,229,532Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · CA
Pediatric Oncology Branch Behavioral Science Core
$1,225,916John Glod · Division Of Basic Sciences - Nci · ZID · FY2022 · CA